Biofilms Research Center for Biointerfaces
for Biointerfaces
Our vision is to shape novel solutions for improved health through excellent science in partnership with industry.
Thérese Nordström, Director
Facts and figures
Facts & Figures
12 Professors
44 PhD and Post docs
13 Assoc. Prof. and lecturers
Scientific publications
Highlights
Biobarriers and pharmaceutical design
Biobarriers and pharmaceutical design include pharmaceutical formulation, transdermal and mucosal drug delivery as well as hydration of biological interfaces, proteins and nanoporous materials.
The research in detail
Hydration of biological interfaces, proteins and nanoporous materials
The functional properties of biological materials and nanomaterials are strongly dependent on their interactions with the surrounding environment, where the presence of water in the form of liquid or vapour is inevitable. We have a special interest in nanoporous materials, such as mesoporous silica, and we study their hydration, characterisation and interactions with organic molecules and biomolecules. We also study the hydration of carbohydrate materials, such as cellulose. In the drug delivery field, we work with the interaction of solid excipients with water; hydration of proteins; hydration and phase transitions in lipids; and hydration of biological barriers.
Pharmaceutical formulation
In the development of transdermal and topical formulations it is important to understand how formulation ingredients interact with the molecular components of the skin barrier and thereby influence its macroscopic barrier properties. Our research activities focus on the effects of commonly used excipients and other chemicals, such as penetration enhancers, on the molecular, as well as the macroscopic, properties of the skin membrane. We also investigate how nanomaterials, such as mesoporous silica particles, can be used in controlled release applications. The advantage of mesoporous silica, such as MCM-41 and SBA-15, is that these materials have remarkable properties due to their well-defined structure with tunable pore diameter and narrow pore size distribution, which can be optimised for loading and controlled release of drugs or biomolecules.
Transdermal and mucosal drug delivery
The skin barrier (the stratum corneum) is an effective permeability barrier. Despite this, the skin is an attractive alternative to the oral route for drug delivery because it avoids first pass metabolic degradation, which can be an important advantage for certain drugs. Two common strategies to overcome the skin barrier for increased transdermal drug delivery are to increase skin hydration and add a penetration enhancer. Our research focuses on how hydration affects skin permeability, with and without penetration enhancers. Our approach is to combine several experimental methods to obtain both macroscopic and molecular scale information on how hydration and penetration enhancers influence the stratum corneum.
Biobarriers
We focus on advancing the knowledge of the key physicochemical properties of biointerfaces, and how they determine the interactions with biomolecules in solutions. In order to achieve this, we develop biomimetic systems that aim at mimicking specific biobarriers in an easily producible and reproducible manner. The biobarriers we are interested in include cellular membranes, plant cell walls and blood vessels. Currently, we are applying these biomimetic systems to improve our understanding of the onset and treatment of various diseases such as atherosclerosis and bacterial infections.
Research projects
Biomimetic membranes for revealing the function and structure relationship of menbrane bound proteins and other biomolecules
M. Cardenas
Dermal drug delivery - How to increase bioavailability in viable skin
Development and formulations centre for next generation biologics - NextBioForm
Experimental studies of hydration of polyhydroxyalkanoates
V. Kocherbitov
Kinetics of starch gelatinization
V. Kocherbitov
Lipoprotein structure in the bulk and at the surface of vessel wall components
Biofilms at interfaces
Microorganisms have a strong tendency to associate with surfaces and form adherent microbial communities, known as biofilms. Within this field, we study mechanisms by which bacteria adapt to and survive in the biofilm environment, as well studying the salivary and mucosal barrier.
The research in detail
Oral microbiology
In any environment, macromolecules and micro-organisms have a strong tendency to associate with surfaces and form adherent microbial communities, so-called biofilms, which are now recognised as the cause of most infectious diseases. Our goal is to understand the mechanisms by which oral bacteria acquire virulence in biofilms and to identify key points of intervention. We anticipate that our results will contribute to the development of future anti-microbials that target disease-inducing properties in biofilms rather than specific microorganisms.
Saliva research
Our main focus is the study of salivary pellicles — the film of nanometric dimensions that forms immediately upon contact of saliva with almost any type of surface. Pellicles play an important role in the maintenance of oral health, as they protect and lubricate oral surfaces. Our aim is to better understand the mechanisms underlying salivary lubrication. We also study the mechanisms underlying the protection offered by salivary pellicles against dental erosion and how this can be improved by complementing acidic beverages with anti-erosive compounds.
Biotherapeutics
Bacterial proteases are a driving force for the inflammatory responses involved in both periodontitis and cardiovascular disease. Our aim is to develop advanced technological tools based on an array of biomarkers (bacterial proteases and inflammatory mediators) to aid the identification of individuals at risk of severe alveolar bone loss disease, as well as the prediction and treatment of periodontal disease and associated inflammatory disorders.
Research projects
Bacterial acid tolerance - a new target for fluoridated milk
Biomarkers and biotherapeutics for polymicrobial infections and inflammation
Hydration-Induced Phase Transitions in Surfactant and Lipid Films
S. Björklund
Nano and micro scale characterization of coatings in relation to their functional properties
Outside-in signaling in oral streptococci during biofilm formation and acid tolerance development
Regulation of Surface Protein Presentation on Streptococcus gordonii
Smart materials at interfaces
Smart materials at interfaces include bioelectronics (biosensors and biological power sources), oral implants and artifical biomimicry with biological applications.
The research in detail
Biosensors and implantable bioelectronics
Research on biosensors and implantable bioelectronics is focussed on development of specific analytical devices and methods for monitoring clinically relevant analytes and biomarkers, as well as the development of potentially implantable electric power devices. It includes synthesis and characterisation of nanomaterials, development of novel sensing and power generating principles, as well as assessment of biosensor and biofuel cell performance in clinical and implantable situations. Our research strength lies in electrochemical sensors and enzymatic fuel cells. Lately, we have exploited biosensor approaches for the investigation of processes at biological barriers, tested enzymatic fuel cells in human blood under homeostatic conditions, as well as disclosed a new type of bioelectronic device – self-charging biosupercapacitors.
Mathematical modelling
Scientific computing and simulations of phenomena on micro and macroscopic scales is a field of great scientific importance. General mathematical techniques, such as differential equations, combined with computational methods, allow a very broad range of applications. Our main focus is on three different areas: computational quantum physics; modelling of infectious diseases; and resonance spectrum for stratified media.
Artficial biomimicry
Biomimicry (defined as the imitation of life or nature) is used in biomedicine and biotechnology to develop novel treatments and diagnostic methods. We focus on two major areas within biomimicry. The first being the development of novel diagnostic tools for cancer. And secondly, biomimetic systems for better understanding of the onset and treatment of diseases including atherosclerosis and bacterial infections.
Finding new and better ways to diagnose and treat cancer is one of a pressing task for researchers. Early diagnosis, where the cancer is still curable, is therefore crucial. This emphasises the need for sensitive, robust and affordable diagnostic tools that can sense the cellular state, commonly in the form of tumour-specific protein markers, early on in the process. We are developing and using molecularly imprinted polymers, plastic antibodies and other smart materials to detect and sense previously inaccessible tumour markers and discover novel disease biomarkers.
Research projects
Biofuel Cells: From Fundamentals to Application in Bioelectrochemistry S.Shleev
MgBone
S. Galli
Non-invasive multi-parameter biomedical devices: Disclosing hidden fitness and health indicators
Phase field modeling: crack-induced third-phase formation in bi-material systems
C. Bjerkén, C.Nigro
Screening of different surface coatings on titanium including different API´s for enhanced wound healing
L. Lindh
Surface modification with natural as well as artifical active substances of dental materials with the aim to promote and keep good health for the spare part human
L. Lindh
SynchroLoad
S. Galli
The BioCapture Network - Smart Capture Phases for Proteomics, Glycomics and Biomarker Assays
BioCapture — developing new cancer diagnostic tools
Early diagnosis of cancer, where it's still curable, is crucial. We need sensitive, robust and affordable diagnostic tools that can sense tumour-specific protein markers early on in the process.
Glycoimaging — The hunt for cancer cells
In order to locate cancer cells we need new diagnostic methods. The EU-funded Glycoimaging project addresses the need for effective diagnostic tools, while exploiting novel synthetic probes targeting tumour-specific glycans.
Finding answers to the puzzle of cholesterol
Atherosclerosis is a major cause of heart attacks and is linked to the body’s levels of so-called ‘good’ and ‘bad’ cholesterol. Professor Marité Cardena's research group is using artificial tools to understand how cholesterol affects the risk of atherosclerosis. Watch the interview with Cardenas to learn more about the project.
Advisory Board
Cristina Glad, CEO, Chairperson, C Glad Consulting AB
Tomas Lundqvist, Senior Coordinator Research Infrastructures, RISE — Research Institutes of Sweden
Sven Frökjaer, Vice-Dean, Faculty of Health and Medical Sciences, University of Copenhagen
Karin Bryskhe, CEO, Colloidal Resource AB and CR Development AB
Thomas Arnebrant, Professor of Biointerfaces, Vice Dean, Faculty of Heath and Society
Gunnel Svensäter, Professor of Oral Health, Faculty of Odontology
Martina Kvist Reimer, Executive Vice President, Red Glead Discovery
Working committee
Julia Davies, Professor
Alexei Iantchenko, Professor
Tautgirdas Ruzgas, Professor
Johan Engblom, Professor
Liselott Lindh, Professor
Industry partners
Covercast AB
Samsung, South Korea
